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Abstract
Background: The prevalence of axial spondyloarthritis (axSpA) is estimated between 0.15 and 1.2%, with many of
those patients experiencing severe fatigue. Current axSpA assessment guidance recommends use of a single-item
visual analogue scale for fatigue severity. However, concerns have been raised about the ability of such a limited
assessment to identify patients with major fatigue, to detect important change in fatigue or to reflect the multi-
dimensional nature of fatigue. The proposed systematic review will identify and evaluate the quality and acceptability
of single- and multi-item patient-reported outcome measures (PROMs) used to assess fatigue in axSpA, seeking to
make recommendations for the ‘best’ measures for research and/or clinical practice.
Methods/design: The review will seek to include published studies which report evidence of the development and/or
measurement and/or practical properties of clearly defined and reproducible measures of fatigue following completion
by patients with axSpA. Five major databases will be searched from 1980 to August 2017: MEDLINE (OVID), EMBASE
(OVID), PsycINFO (OVID), World of Science and CINAHL. Study methodological quality will be assessed against the
COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. The measurement
and/or practical properties of reviewed measures will be assessed against current international standards. A short list of
the ‘best’-quality PROMs will be produced. The review will be reported in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Discussion: This study will provide the first robust and transparent evaluation of patient-reported measures of fatigue
used in the axSpA population, synthesising evidence of quality, relevance and acceptability. The review will benefit
patients, clinicians, health professionals and researchers wishing to enhance axSpA-fatigue assessment in routine
practice, service evaluation and research. The findings will impact future research which seeks to better understand
the nature of axSpA fatigue and evaluate the relative benefit of fatigue-management strategies.
Systematic review registration: PROSPERO CRD42016042271
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Background
Axial spondyloarthritis (axSpA) is an inflammatory dis-
ease that primarily affects the spine and pelvis, impairing
mobility to the detriment of the patient’s physical well-
being [1]. It is characterised by widespread back and joint
pain and stiffness [2]. axSpA and ankylosing spondylitis
(AS) are two facets of a single disease distinguished by
whether radiographic sacroiliitis is observable by X-ray
examination (AS) or not (axSpA) [2]. Up to 75% of axSpA
patients report experiencing fatigue [3–7], and for many,
this is both severe and frequent [7]. Patients with AS have
highlighted the relative importance of seeking to better
understand the fatigue associated with their illness [8],
underlining the need for an appropriate fatigue assess-
ment that really captures what matters to patients. As
exemplified in rheumatoid arthritis (RA), a review of
methods of fatigue assessment [9] and qualitative research
with patients highlighted both the multi-faceted nature of
RA fatigue [10] and the inadequacy of current methods of
assessment. The result was the development of a patient-
reported outcome measure (PROM) specific to RA
fatigue—the Bristol Rheumatoid Arthritis Fatigue Multidi-
mensional Questionnaire (BRAF-MDQ) [11, 12]. PROMs
are single- or multi-item questionnaires which seek to
provide a patient-derived assessment of how they feel,
what they can and cannot do and how well they are living
their lives as a consequence of their health and associated
health care [13].
Current assessment guidance for AS exists in the form
of a core outcome set (COS) [14]. The COS provides
guidance for the minimum number of outcomes to include
in future clinical practice and clinical trials: that is, pain,
stiffness, function, global wellbeing and spinal mobility
[14, 15]. A recent update recommends the assessment
of fatigue severity with a single-item visual analogue
scale (VAS) [16]. However, evidence from a large UK
cohort of AS patients highlighted significant limitations
with a single-item assessment of fatigue, including the
failure to identify some patients with major fatigue, to
detect important change in fatigue, to reflect the multi-
dimensional nature of fatigue or to detail the nuances
of fatigue essential to driving tailored healthcare.
A growing number of multi-item fatigue-specific (for
example, the Multidimensional Fatigue Inventory (MFI-20)
[17] and Fatigue Severity Scale [18]) and condition-fatigue-
specific (for example, the BRAF-MDQ [12] and Functional
Assessment of Cancer Therapy scale [19]) PROMs are now
available. This growth in availability reflects the importance
of capturing the multi-faceted, often condition-specific,
nature of fatigue [20] and the importance of seeking to
reflect the outcomes that really matter to patients [21].
However, it is unclear how well these measures perform
in the axSpA population; it cannot be assumed that the
measurement and practical properties of measures are
consistent across different patient populations. Confi-
dence in the use of PROM-based assessment is under-
pinned by evidence of performance in the population of
interest [22], and structured reviews of PROM quality
and acceptability provide essential evidence to inform
selection.
The proposed systematic review will evaluate the quality
(measurement properties), relevance (measures what is
important) and acceptability (simplicity and convenience)
of clearly defined and reproducible multi- and single-item
PROMs which purport to measure fatigue and have
been completed by the axSpA population. A short list
of ‘best’ measures of fatigue for use with the axSpA
population will be developed to inform recommenda-
tions for use in both routine clinical practice and
research.
Method/design
The review will include published studies reporting evi-
dence of the development, measurement and/or practical
properties of clearly defined and reproducible measures of
fatigue evaluated following completion by patients with
axSpA. The review will be completed and reported in ac-
cordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [23].
Study methodological quality will be assessed against
the COnsensus-based Standards for the selection of
health Measurement INstruments (COSMIN) guidelines
[24, 25]. The measurement and/or practical properties of
included measures will be assessed against a transparent
appraisal framework informed by current international
standards for PROM quality [22, 26–29].
Search strategy
A comprehensive search strategy will be developed using
Medical Subject Headings (MeSH) and free text searching
to reflect four key characteristics [26, 30, 31]: (1) popula-
tion—axSpA, (2) construct—fatigue, (3) type of assess-
ment—patient-reported measures and (4) measurement
properties (a modified version of a sensitive search filter
and accompanying exclusion filter) [30] (example search
in Additional file 1: Appendix 1).
Following the review of titles and abstracts of included
studies, a further ‘named measure’ search will be
developed and applied with search terms developed as
above to reflect (1) population—axSpA, (2) construct—
fatigue, (3) named fatigue measures and (4) measurement
properties.
The search strategy will be modified for each of the
following databases: MEDLINE (OVID), EMBASE
(OVID), PsycINFO, World of Science and CINAHL.
Searches will be run from 1980 to August 2017.
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Stage 1: Identifying evaluative studies of PROM-based
fatigue assessment in axSpA
The search strategy will use MeSH, keywords and syno-
nyms to identify studies of adult patients with axSpA where
the concept of fatigue is assessed. To ensure maximal
sensitivity, a wide range of terms will be used to reflect
the target patient sample (axSpA) and fatigue. A modi-
fied filter describing measurement and assessment will
be used to identify studies using PROMs (original filter
developed by the PROM group and Knowledge Centre,
Department of Public Health, University of Oxford).
Terms describing the measurement evaluation will be
searched for using a modification of the COSMIN filter
[30]. The recommended COSMIN exclusion filter will
be added to the search string [30].
Titles and abstracts will be reviewed for inclusion by one
reviewer (NP); a second reviewer (KH) will independently
review a 10% subset of randomly selected titles and abstracts
and agreement checked [32, 33]. A third independent re-
viewer (JP) will resolve any differences regarding eligibility.
Reference lists of included articles will be screened for
additional articles. The reason(s) for any full-text exclu-
sions will be recorded.
Review inclusion/exclusion criteria
Study inclusion
Studies will be included if they (i) include a clearly identifi-
able and reproducible PROM-based assessment of fatigue;
(ii) the study reports evidence of the development and/or
evaluation (practical or measurement properties) of the
PROM following completion by members of the axSpA
population; and (iii) the study has been published, peer-
reviewed, is available as a full text and is written in English.
Studies will be excluded if they are (i) available as abstract
only; (ii) the assessment of fatigue is not patient-reported,
clearly identifiable or reproducible; (iii) the study simply
describes use/application of a PROM without further
evidence of measurement/practical properties; (iv) the
measurement and/or practical properties cannot be
extracted specific to the axSpA population; or (v) the
study has not been published, peer-reviewed or is not
available in English.
All abstracts that include patients with psoriatic arthritis
(PsA) will be screened by a consultant rheumatologist (JP)
and included if a subset of patients is clinically defined as
having axSpA and separately reported.
PROM inclusion
PROMs will be included if (i) they are fatigue specific:
both multi-item and single-item measures will be included
and (ii) fatigue is assessed as a separate domain within a
multiple domain assessment (e.g. SF-36 Vitality [34]). As-
sessments of fatigue will not be included if they are (i)
clinician-reported or (ii) a non-PROM-based assessment.
Stage 2: Identifying studies using named PROM-based
fatigues measures in axSpA
The search strategy will use the search filters developed
in stage 1 for population (axSpA), construct (fatigue) and
measurement properties (COSMIN filter). In addition, a
named measures search filter will be developed and added
to the search string to identify single- and multi-item
measures used in axSpA fatigue assessment. All identified
titles and abstracts will be extracted, and any duplicates
between stage 1 and 2 searches will be removed. Title and
abstract screening will follow the same procedure outlined
for the stage 1 search (see stage 1), and the same eligibility
criteria will be applied.
Data extraction and appraisal
Data extraction will be informed by previous reviews
[35, 36] (see Additional file 1: Appendix 2) and the re-
quirements of the COSMIN checklist [24, 25]. COSMIN
provides a transparent appraisal system that is internation-
ally developed. The checklist contains quality criteria for
evaluating ten measurement properties—validity (content,
structural, construct, criterion, cross-cultural), reliability
(internal consistency, test-retest, measurement error),
responsiveness and interpretability. This review will
consider all evidence of measurement evaluation that
relates to fatigue-specific measures only.
Data extraction will capture (1) study information (popu-
lation, definition of fatigue, language) and (2) PROM-based
information. PROM-based evidence of measurement
properties will include validity (structural, content and
face, construct, criterion, longitudinal), reliability (inter-
or intra-rater, test-retest, internal consistency, measure-
ment error), responsiveness (criterion or construct-based)
and interpretability (minimal important change, smallest
detectable change, response shift). Evidence for the
practical properties of PROMs will include acceptability
(relevance) and feasibility. The extent of patient involve-
ment as active research partners in PROM development,
evaluation and/or application will be sought [37].
Study methodological quality for each reported meas-
urement property will be assessed using the COSMIN
checklist 4-point scale (i.e. poor, fair, good, excellent)
[24, 25]. Two reviewers (NP and KH) will independently
undertake data extraction and apply the COSMIN
checklist on a randomly selected 10% subset of included
papers. Any disagreements are resolved through discus-
sion with a third reviewer (JP or HP).
Data synthesis
Data synthesis will seek to contextualise evidence of the
reported measurement and/or practical properties along-
side the methodological quality of the study. As per earlier
reviews, data synthesis will consider (i) study methodo-
logical quality (COSMIN scores), (ii) the number of studies
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reporting evidence per fatigue measure, (iii) the results for
each practical and measurement property per measure,
and (iv) consistency between evaluations [35]. Data synthesis
will report two pieces of information. First, measurement
property quality will be categorised as adequate (+), not
adequate (−), conflicting (+/−) or unclear (?). Second,
the strength of evidence for the quality of each measure-
ment property reviewed will be categorised as ‘strong’,
‘moderate’, ‘limited’, ‘conflicting’ or ‘unknown’ [32, 35].
Following data synthesis and item-content comparisons,
PROM recommendations will be informed by (1) whether
and to what extent essential domains of fatigue identi-
fied—as per the RA-fatigue model—are reflected within
the PROM (content validity), (2) the availability of
adequate evidence of minimally important measurement
properties—validity (structural and construct) and reliability
(internal consistency and test-retest), and (3) an evidence
base that is minimally judged to be of moderate quality.
Discussion
Awareness of the importance of fatigue in inflammatory
conditions has grown over the past decade [20]. Whilst
patients report fatigue as one of the key symptoms of
their condition, there is limited evidence of an improved
understanding of fatigue in axSpA and its impact on
patients’ lives [3, 38, 39]. Moreover, growing evidence
suggests that the experience of fatigue is not homogeneous
across conditions [10, 40] and hence a generic approach to
assessment may miss important aspects of fatigue for
particular patient groups.
This study will provide the first robust and transparent
evaluation of patient-reported measures of fatigue used in
the axSpA population, synthesising evidence of quality,
relevance and acceptability. The findings of this review
will inform the selection of patient-reported fatigue assess-
ment, thus impacting future research which seeks to
better understand the nature of axSpA fatigue. Improving
the assessment of fatigue in routine practice, service
evaluation and research will enhance our understanding
of the way in which fatigue impacts upon the lives of
people with axSpA, and the way in which their fatigue
responds to fatigue-management strategies.
Additional file
Additional file 1: Appendix 1. Search strategy. Appendix 2. Quality
criteria to appraise reported measurement properties [28, 36]. (DOCX 25 kb)
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